CarrTech
CarrTech: Pioneering safer, efficient, cost-effective solutions for preparing ampoule-based medications.
Founded
2021CarrTech: Pioneering safer, efficient, cost-effective solutions for preparing ampoule-based medications.
CarrTech is a medical device company dedicated to addressing the unsafe and complicated problem of filtering ampoule-based medications. Founded with the mission of enhancing safety, efficiency, and cost-effectiveness in medical preparations, CarrTech has developed and patented FROG® (Filter Removal of Glass), the first and only integrated all-in-one package combining a filter and hypodermic needle. This innovative device aims to streamline the medication preparation process, reducing risks of injury and patient death while cutting healthcare costs and waste.
Notable figures affiliated with CarrTech include its founder, Sue Carr, who has been instrumental in driving the company's vision. The company has garnered attention from investors focused on healthcare innovation, contributing to its growth and development. CarrTech's key achievements include securing patents for its groundbreaking device and receiving positive feedback from medical professionals for improving efficiency and patient care. Overall, CarrTech's impact lies in its potential to revolutionize the preparation of ampoule-based medications, making healthcare practices safer and more efficient.
Companies similar to CarrTech include Careier, TuCann Medical, Portal Instruments and SonoSolve.
CarrTech was founded in 2021.
CarrTech's headquarters is located in Frederick, MD, US.
CarrTech's most recent funding round was for $250k (USD) in December 2022.
As of Dec 26, 2022, CarrTech has disclosed funding of $2.3M (USD). Undisclosed round amounts are excluded.
CarrTech has 8 employees as of Feb 4, 2024.
SonoSolve
